ASTMH 64th Annual Meeting

  • 25 - 29 October 2015
  • Location: Philedelphia, USA

“Research for an unexpected epidemic: The EU response against Ebola”
Monday, October 26, 7:15 – 9:00 p.m.
Philadelphia Marriott Downtown


Session Description: This symposium aims to present the European research response to the Ebola outbreak, focusing on the challenges and opportunities it revealed for all research partners. The major funder of EU Ebola research, the European Commission, will present an overview of the various funding mechanisms mobilised for this outbreak including collaboration with the pharmaceutical industry, as well as the spectrum of research gaps addressed. Industry and academic researchers will then present the most important European research projects against Ebola, the multiple and diverse challenges they faced and how they managed to overcome them, as well as their results and implications for future research. The session will culminate in a discussion on the lessons learned from this outbreak. A paradigm on how established networks of cooperation among funders can facilitate a coordinated research response to an epidemic like Ebola will be presented.




Cornelius Schmaltz
European Commission Directorate-General for Research and Innovation, Brussels, Belgium
Bruno Gryseels
Institute of Tropical Medicine, Antwerp, Belgium


The EU Research Response to the Ebola Crisis [PDF]
Cornelius Schmaltz
European Commission’s Directorate-General for Research and Innovation, Brussels, Belgium


Joining Forces with Industry: Vaccine Development [PDF]
Johan Van Hoof
Janssen Pharmaceuticals, Beerse, Belgium


Q&A on EC Research Funding Tools, IMI, Vaccine Trial

Study Design Options for Therapeutic Trials – Ethics, Settings and Practicalities [PDF]
Peter Horby
Oxford University, Oxford, United Kingdom


Trials of Convalescent Blood/Plasma [PDF]
Johan van Griensven
Institute of Tropical Medicine, Antwerp, Belgium


The JIKI Trial [PDF]
Daouda Sissoko
INSERM, Bordeaux, France


Q&A on Clinical Trials

Cooperation between Funders Benefits Research [PDF]
Penny Heaton
Bill & Melinda Gates Foundation, Seattle, WA, United States


The Way Forward: GIoPID-R [PDF]
Marc Ouallette
Canadian Institutes of Health Research, Institute of Infection and Immunity, Quebec City, QC, Canada


Panel Discussion: Challenges and Lessons Learned